Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Independence Day
Social Media
Artificial Intelligence
European Union
Donald Trump
Taxes
Soccer
Netflix
Heatwaves
Fire
Infrastructure
Stock Markets
Published • loading... • Updated

Chimeric Diphtheria Toxin-CCL8 Cytotoxic Peptide for Breast Cancer Management

Summary by Stemwell Science News
The specificity of a chimeric cytotoxic peptide was confirmed in vitro by testing the cytotoxic activity of breast cancer cells overexpressing CCR5, a major CCL8 receptor, and by a neutralizing anti-CCL8 antibody they developed. [Molecular Oncology] Full Article
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Stemwell Science NewsStemwell Science News

Chimeric Diphtheria Toxin-CCL8 Cytotoxic Peptide for Breast Cancer Management

The specificity of a chimeric cytotoxic peptide was confirmed in vitro by testing the cytotoxic activity of breast cancer cells overexpressing CCR5, a major CCL8 receptor, and by a neutralizing anti-CCL8 antibody they developed. [Molecular Oncology] Full Article

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stemwell Science News broke the news in on Thursday, July 3, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal